Most of the current research on Cav-1 in breast cancer has demonstrated that loss of Cav-1 expression in the stromal cells surrounding the tumor is associated with early tumor recurrence and poor clinical outcome [5,6]. This evidence concerns the gene CAV1 and breast cancer.